Adressing complicated pregnancies, iPremom raises €15 million to advance early detection
iPremom, a Spanish molecular diagnostics company addressing the early identification of pregnancy complications, has raised €15 million in Seed funding to support clinical validation and the commercial rollout of its MaiRa platform, which analyses early signals of first-trimester pregnancy complicat
<p>iPremom, a Spanish molecular diagnostics company addressing the early identification of pregnancy complications, has raised €15 million in Seed funding to support clinical validation and the commercial rollout of its MaiRa platform, which analyses early signals of first-trimester pregnancy complicat</p>